Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Sculptor Capital LP SOC Sable Offshore Corp. 13G/A 4.53% 2y
LW CAPITAL MANAGEMENT, LLC LFCR Lifecore Biomedical, Inc. De 13G 5.2% 2y
PRICE T ROWE ASSOCIATES INC /MD/ AKRO Akero Therapeutics, Inc. Common Stock 13G 6.6% 2y
RA CAPITAL MANAGEMENT, L.P. GERN Geron Corp 13G/A 9.99% 2y
CANNELL CAPITAL LLC STIM Neuronetics, Inc. 13G/A 9.57% 2y
Commodore Capital LP AMAM Ambrx Biopharma, Inc. Common Stock 13G/A 0% 2y
First Trust Capital Management L.P. KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares 13G 8.41% 2y
VIKING GLOBAL INVESTORS LP VSTM Verastem, Inc. 13G/A 9.99% 2y
EMINENCE CAPITAL, LP MANU Manchester United plc 13G 8.9% 2y
Sessa Capital Special Opportunity Fund II, L.P. AIV Apartment Investment & Management Co 13G/A 0% 2y
QVT Financial LP ROIV Roivant Sciences Ltd. 13G/A 13.97% 2y
Deep Track Capital, LP TVTX Travere Therapeutics, Inc. 13G/A 9.99% 2y
BOOTHBAY FUND MANAGEMENT, LLC CNTM ConnectM Technology Solutions, Inc. 13G/A 0.2% 2y
AQR CAPITAL MANAGEMENT LLC SPEC Spectaire Holdings, Inc. Common Stock 13G/A 0.86% 2y
Alyeska Investment Group, L.P. UBX Unity Biotechnology, Inc. Common Stock 13G/A 9.99% 2y
TURTLE CREEK ASSET MANAGEMENT INC. BERY Berry Global Group, Inc. 13G/A 3.4% 2y
Mark Zuckerberg META Meta Platforms, Inc. 13G/A 13.6% 2y
Alger Associates, Inc. 13-3017981 FBRX Forte Biosciences, Inc. 13G/A 5.1% 2y
Smith Edgar R. III FGBI First Guaranty Bancshares, Inc. 13D/A 8.52% 2y
Jean M. George CYT Cyteir Therapeutics, Inc. Common Stock 13G/A 6.9% 2y
Advent International, L.P. CINT CI&T Inc 13G/A 70.4% 2y
Solel Partners LP BIOX Bioceres Crop Solutions Corp. 13G/A 7.3% 2y
First Trust Capital Management L.P. ESHA ESH Acquisition Corp. 13G 6.34% 2y
T. Rowe Price Investment Management, Inc. LSCC Lattice Semiconductor Corp 13G 8.9% 2y
Avidity Partners Management LP KPTI Karyopharm Therapeutics Inc. 13G/A 9.5% 2y
T. Rowe Price Investment Management, Inc. NRDS Nerdwallet, Inc. 13G 5.2% 2y
ALLIANCEBERNSTEIN L.P. FLYW Flywire Corp 13G/A 4.2% 2y
Pfizer Inc CLLS Cellectis S.A. 13G/A 3.89% 2y
METEORA CAPITAL, LLC CPTKW Crown PropTech Acquisitions 13G 9.9% 2y
FIR TREE CAPITAL MANAGEMENT LP APXI APx Acquisition Corp. I Class A Ordinary Share 13G/A 1.18% 2y
T. Rowe Price Investment Management, Inc. AUR Aurora Innovation, Inc. 13G/A 10.1% 2y
D. E. Shaw & Co., L.P. HCVI Hennessy Capital Investment Corp. VI Class A Common Stock 13G/A 3.4% 2y
Sculptor Capital LP CDAQF Compass Digital Acquisition Corp. 13G/A 0% 2y
683 Capital Management, LLC SBNY Signature Bank 13G/A 1.5% 2y
Nantahala Capital Management, LLC ASRT Assertio Holdings, Inc. 13G 8% 2y
MWE Investments Limited MWG Multi Ways Holdings Ltd 13G 66.75% 2y
Cormorant Asset Management, LP KRRO Korro Bio, Inc. 13G/A 6.61% 2y
ADW Capital Partners, L.P. PAR Par Technology Corp 13G/A 9.6% 2y
REDWOOD CAPITAL MANAGEMENT, LLC APEI American Public Education Inc 13G/A 7.94% 2y
Katrina Lake SFIX Stitch Fix, Inc. 13G 10% 2y
RedOne Investment Ltd LBBB Lakeshore Acquisition II Corp. Ordinary Shares 13G/A 57.03% 2y
VIKING GLOBAL INVESTORS LP EWTX Edgewise Therapeutics, Inc. 13G/A 9.7% 2y
ARMISTICE CAPITAL, LLC GNLN Greenlane Holdings, Inc. 13G 9.99% 2y
Woodson Capital Management, LP NDLS NOODLES & Co 13G/A 0% 2y
MENORA MIVTACHIM HOLDINGS LTD. NVMI Nova Ltd. 13G/A 7.2% 2y
Lagoda Investment Management, L.P. VNRX Volitionrx Ltd 13G/A 4.7% 2y
BROWN CAPITAL MANAGEMENT LLC APPF Appfolio Inc 13G/A 7.33% 2y
PRICE T ROWE ASSOCIATES INC /MD/ KSS KOHLS Corp 13G 8.4% 2y
Crestview Partners II GP, L.P. CWH Camping World Holdings, Inc. 13G/A 17% 2y
ArrowMark Colorado Holdings LLC HCCI Heritage-Crystal Clean, Inc. 13G/A 0% 2y